Global Sperm Count Test Market Size, Share, and COVID-19 Impact Analysis, By Technique (Microscopy, Chromatographic Immunoassay & Calorimetric Reaction, and Smartphone-based), By Age Group (34 & Below, 34 Years, 35-40 Years, and 41 Years & Above), By End-User (Fertility Centers, Hospital & Clinics, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033.

Industry: Healthcare

RELEASE DATE Jun 2024
REPORT ID SI4527
PAGES 250
REPORT FORMAT PathSoft

Global Sperm Count Test Market Insights Forecasts to 2033

  • The Global Sperm Count Test Market Size was Valued at USD 2.1 Billion in 2023
  • The Market Size is Growing at a CAGR of 6.60% from 2023 to 2033
  • The Worldwide Sperm Count Test Market Size is Expected to Reach USD 3.98 Billion by 2033
  • Asia Pacific is Expected to Grow the fastest during the forecast period.

Global Sperm Count Test Market

Get more details on this report -

Request Free Sample PDF

The Global Sperm Count Test Market Size is Anticipated to Exceed USD 3.98 Billion by 2033, Growing at a CAGR of 6.60% from 2023 to 2033.  

 

Market Overview

A diagnostic test called a sperm count test, or semen analysis, is used to determine the quantity and quality of sperm in a man's semen. Because it is able to estimate a man's capacity to father a child, it is a significant indication of male fertility. The test is often conducted in a laboratory by a qualified specialist who takes a sample of sperm, which is then examined under a microscope to ascertain the quantity of sperm present. Men can diagnose reproductive problems and choose the best course of action for their condition with the aid of the results of a sperm count test. The main factor driving the expansion of sperm count test use is an increase in male infertility patients. Three main aspects of sperm viability are measured by a semen analysis: the quantity of sperm and their form, and the sperm's motion, sometimes referred to as sperm motility. Test results may be adversely affected by a number of variables, including semen coming into contact with spermicide, taking the test while unwell or under stress, and sample contamination due to lab worker error. Growing consumer awareness of fertility tests is a major factor propelling the market's expansion. About 15% of couples worldwide experience infertility, with male factors contributing to up to 50% of cases, according to the WHO. This has caused attention to focus more on male infertility and the role that sperm count testing plays in determining the underlying cause of infertility. A number of advocacy groups and healthcare organizations are also launching campaigns to increase public awareness of male infertility and the value of fertility testing. Among these initiatives is a public education campaign regarding the availability and advantages of sperm count testing, as well as the causes and risk factors of male infertility.

 

Report Coverage

This research report categorizes the market for the global sperm count test market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global sperm count test market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global sperm count test market.

 

Global Sperm Count Test Market Report Coverage

Report CoverageDetails
Base Year:2023
Market Size in 2023:USD 2.1 Billion
Forecast Period:2023-2033
Forecast Period CAGR 2023-2033 :CAGR of 6.60%
2033 Value Projection:USD 3.98 Billion
Historical Data for:2019-2022
No. of Pages:250
Tables, Charts & Figures:110
Segments covered:By Technique, By Age Group, By End-User, By Region
Companies covered::Fertility Focus Inc, Vitrolife AB, Hamilton Thorne, ExSeed health, AB ANALITICA s.r.l., Medical Electronic Systems, Andrology Solutions, DxNow, Artron Laboratories Inc, Olympus Corporation Inc, Mojo, MICROPTIC, Thermo Fisher Scientific Inc., and other key companies.
Pitfalls & Challenges:Covid-19 Empact, Challenges, Growth, Analysis, Lack of awareness in developing countries High cost of test

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

The rising prevalence of infertility among couples globally is a major reason driving the sperm count test market. Sperm count testing helps identify possible problems with male infertility early on. They offer crucial information on motility and sperm count to aid in the diagnosis of male infertility issues. The future is predicted to see a rise in the use of sperm count tests due to the increasing significance of early testing and proactive fertility management. Furthermore, the market is expanding due to the increasing availability of simple and reliable at-home sperm count testing kits. Companies are concentrating on creating sperm cunt kits that are easy to use at home. The demand for at-home sperm tests is growing, and this presents potential opportunities for the global market for sperm count tests. Acceleration, accuracy, and efficiency are being improved in sperm analysis devices by the integration of cutting-edge technologies, including microfluidics, lab-on-a-chip, and AI. In order to analyze semen quickly and identify abnormalities, companies are creating automated sperm counting systems and computer-aided sperm analysis (CASA) systems that are coupled with AI algorithms. These developments are encouraging uptake while offering chances for expansion.

 

Restraining Factors

Modern automated sperm counts and semen analysis devices are expensive, requiring large capital expenditures for purchase. Due to their high ownership costs, small clinics and hospitals with tight budgets are unable to purchase or adopt them. Affordability is further restricted by regional differences in fertility test reimbursement and insurance coverage. Men's fertility testing is still filled with stigma and privacy issues, which makes it a major commercial obstacle. Open talks concerning fertility concerns are limited by low awareness and a lack of dialogue. Even with activities centered around men's health support, testing still needs to become more commonplace.  

 

Market Segmentation

The global sperm count test market share is classified into technique, age group, and end-user.

 

  • The microscopy segment is anticipated to hold the largest share of the global sperm count test market during the forecast period.    

On the basis of the technique, the global sperm count test market is divided into microscopy, chromatographic immunoassay & calorimetric reaction, and smartphone-based. Among these, the microscopy segment is anticipated to hold the largest share of the global sperm count test market during the forecast period. Sperm cell examination and analysis are made possible by microscopy, which is a crucial part of sperm count testing. Because microscopy makes it possible to directly view and analyze sperm cells, it produces accurate and trustworthy results for sperm count tests. Furthermore, defects in sperm cells, such as distorted or immotile sperm, can be found by microscopy. This information is useful for determining the male fertility diagnosis.

 

  • The 35-40 years segment is anticipated to hold the highest share of the global sperm count test market during the forecast period.    

On the basis of the age group, the global sperm count test market is divided into 34 & below, 34 years, 35-40 years, and 41 years & above. Among these, the 35-40 years segment is anticipated to hold the highest share of the global sperm count test market during the forecast period. Considering that male fertility tends to drop with age and that this age range constitutes a crucial window for couples seeking to conceive, the 35–40-year-old age group is significant for the market. Furthermore, some of the major driving reasons for the 35–40 age range in the market include postponing childbearing, growing awareness of male infertility, lifestyle choices, health issues, and testing accessibility.

 

  • The fertility centers segment is anticipated to hold the largest share of the global sperm count test market during the forecast period.

 On the basis of end-user, the global sperm count test market is divided into fertility centers, hospital & clinics, and others. Among these, the fertility centers segment is anticipated to hold the largest share of the global sperm count test market during the forecast period. Sperm count tests are an integral aspect of male infertility testing and are conducted on a regular basis in fertility centers to identify infertility in men and create treatment regimens that work. Furthermore, there is a growing need for sperm count testing in reproductive centers due to the growth in male infertility. Therefore, the main driving forces behind the adoption of sperm count testing in fertility facilities are the expansion of the healthcare infrastructure and the greater accessibility of reproductive therapies.

 

Regional Segment Analysis of the Global Sperm Count Test Market

  • North America (U.S., Canada, Mexico) 
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Rest of APAC)
  • South America (Brazil and the Rest of South America) 
  • The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

North America is anticipated to hold the largest share of the global sperm count test market over the predicted timeframe.

 

North America

Get more details on this report -

Request Free Sample PDF

 

North America is anticipated to hold the largest share of the global sperm count test market over the predicted timeframe. The main drivers of the U.S. market include improvements in sperm count testing technology, a supportive regulatory environment, and rising healthcare costs. It is also expected that industry statistics can be stimulated by the increase in in-vitro fertilization services due to rising male infertility rates in the United States. The regulatory landscape for medical equipment and diagnostics, including sperm count testing, is favorable in the United States. This has boosted the availability and accessibility of these tests and prompted the development and commercialization of cutting-edge sperm count testing technology. These factors drive the growth of the sperm count test market over the predicted timeframe.

 

Asia-Pacific is anticipated to grow at the fastest rate in the global sperm count test market over the predicted timeframe. Due to a sizable patient base, rising sperm test adoption rates, and rising healthcare costs, the Asia-Pacific market is expanding. The sudden rise in cases of infertility and the public's growing knowledge of semen analysis tests. However, because sperm count tests are becoming more widely used throughout the province, these factors are anticipated to expand the sperm count test market over the predicted timeframe.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global sperm count test market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

  • Fertility Focus Inc
  • Vitrolife AB
  • Hamilton Thorne
  • ExSeed health
  • AB ANALITICA s.r.l.
  • Medical Electronic Systems
  • Andrology Solutions
  • DxNow
  • Artron Laboratories Inc
  • Olympus Corporation Inc
  • Mojo
  • MICROPTIC
  • Thermo Fisher Scientific Inc.
  • Others

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting And Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Recent Developments

  • In January 2023, Jack Fertility, a new healthcare startup, started its male fertility test. The test would permit men to take a sperm sample at home and submit it to a lab for testing, thereby terminating the need for uncomfortable and unsuitable in-person clinic sessions.

 

  • In June 2021, Fertility Focus announced the new OvuSense Pro professional vaginal sensor, which delivers real-time fertility monitoring for healthcare workers.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global sperm count test market based on the below-mentioned segments: 

 

Global Sperm Count Test Market, By Technique

  • Microscopy
  • Chromatographic Immunoassay & Calorimetric Reaction
  • Smartphone-based

 

Global Sperm Count Test Market, By Age Group

  • 34 & Below
  • 34 Years
  • 35-40 Years
  • 41 Years & Above

 

Global Sperm Count Test Market, By End-User

  • Fertility Centers
  • Hospital & Clinics
  • Others

 

Global Sperm Count Test Market, By Regional

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • Uk
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of the Middle East & Africa

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies